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Abstract
Background: Despite recommendations for outpatient management, low risk patients with lower respiratory tract
infections (LRTIs) are often hospitalized. This survey analyzed perceptions of physicians, nurses, patients and
relatives about feasibility of outpatient management and required duration of hospital stay.
Methods: We performed a prospective, observational questionnaire survey in hospitalized patients with LRTI as
part of a multicenter trial. Treating physicians and nurses, patients and their relatives were asked on admission and
before discharge about feasibility of outpatient treatment over 5 dimensions (medical, nursing, organizational
factors, and patients’ and relatives’ preferences) using continuous scales.
Results: On admission, 12.6% of physicians, 15.1% of nurses, 18.0% of patients and 5.2% of relatives believed that
outpatient treatment would be possible. Before hospital discharge, 31.1% of physicians, 32.2% of nurses, 11.6% of
patients and 4.1% of relatives thought that earlier discharge would have been feasible. Medical factors were the
most frequently perceived motives for inpatient management. These perceptions were similar in all LRTI subgroups
and independent of disease severity and associated expected mortality risks as assessed by the Pneumonia Severity
Index (PSI).
Conclusion: Independent of type and severity of respiratory tract infection, the misperceived high severity and
expected mortality and morbidity were the predominant reasons why treating physicians, nurses, patients and their
relatives unanimously believed that inpatient management was necessary. Better assessment and communication
about true expected medical risks might contribute to a pathway to shorten in-hospital days and to introduce a
more risk-targeted and individually tailored allocation of health-care resources.
Trial Registration: NCT00350987
Background
Lower respiratory tract infections (LRTIs), including
community-acquired pneumonia (CAP), acute bronchitis
and exacerbation of chronic obstructive pulmonary dis-
ease (ECOPD) are the most prevalent, the most fre-
quently fatal and the most expensive infectious diseases
in western countries [1-3]. Inpatient management is
approximately 8 to 20 times more expensive than outpa-
tient treatment, but is preferred by many patients and
physicians [4-8]. Hence, safely reducing the number of
inpatient days and encouraging outpatient treatment
improves the quality of care and is cost-effective [7].
Current guidelines recommend to hospitalize patients
with an increased risk for adverse medical outcome and
to discharge patients as soon as clinical stabilization is
documented [9-11]. For this purpose, the Pneumonia
Severity Index (PSI) is a well validated prediction tool
based on age and medical factors to identify patients at
low risk for 30-day mortality and thus suitable for out-
patient management[12,13]. However, despite recom-
mendation of this prediction tool by professional
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often treated as inpatients [8]. Obviously, other factors
than evidence-based medical parameters embedded in
the PSI - such as nursing and organizational factors,
preferences and beliefs of patients and their relatives -
strongly influence the rate of hospital admissions and
the duration of hospital stays[14,15]. Smaller, previous
studies have shown that patients’ and relatives’ prefer-
ences for site of care are important and are influenced
by beliefs about safety (fear of rapid deterioration at
home or acquiring an infection in hospital), family bur-
den, access to support, or confidence in home-care ser-
vices [14-16]. Still, the complex interplay of different
perceptions towards outpatient management and the
impact on site-of-care decisions and length of hospital
stay remains largely unknown.
To better understand perceptions of physicians,
nurses, patients and relatives about the need for inpati-
ent management of different types and severities of
LRTIs, we conducted a prospe c t i v es u r v e yi np a t i e n t s
enrolled in the multi-center ProHOSP trial [17,18]
about the perceived necessity for inpatient management
and necessary length of hospital stay.
Methods
Study Participants
Data for this study were collected from patients enrolled
in the multicenter ProHOSP study during the first win-
ter season (between October 2006 until June 2007) who
were able and willing to participate[17,18]. Outpatients
and patients with severe dementia, language restrictions,
immediate need for ICU admission and/or immediate
fatal outcome were not included. In addition to patients,
we also surveyed the patients’ physicians, nurses, and
relatives.
A detailed description of the ProHOSP study and
baseline characteristics of the participating hospitals has
been published previously [17,18]. In brief, patients with
clinically suspected LRTIs were consecutively included
from October 2006 to March 2008 in six hospitals in
Switzerland (range of hospital beds: 252 - 694). LRTI
was defined as at least one respiratory symptom (cough,
sputum production, dyspnea, tachypnea, pleuritic pain)
plus one auscultatory finding or sign of infection (core
body temperature >38.0°C, shivers, leukocyte count >10
G/L or <4 G/L cells) independent of antibiotic pre-treat-
ment [9-11,19,20]. CAP was defined as a LRTI along
with a new or increasing infiltrate on chest radiograph
[9,10]. In the absence of focal chest signs or an infiltrate
on chest X-ray, either acute bronchitis [9,10] or exacer-
bation of COPD was considered. Exacerbation of COPD
was defined as a FEV1/FVC ratio below 70% in post-
bronchodilator spirometry. Inclusion criteria for patients
were age = 18 years with a LRTI <28 days of duration.
Patients without informed consent, with severe immu-
nosuppression or chronic infection, intravenous drug
users, patients who had been hospitalized within the
previous 14 days, as well as patients in a terminal stage
of a disease, were excluded.
The primary aim of the ProHOSP study was to com-
pare medical outcomes of patients with LRTIs who were
treated with antibiotics according to enforced evidence-
based guidelines (control group) with those treated
according to a previously tested [21-24] procalcitonin
algorithm (intervention group). A predefined secondary
outcome was the assessment of medical and non-medi-
cal factors that influence hospital admission and length
of stay by the use of a systematic survey questionnaire.
The study was approved by all local Ethic Committees
and registered in the Current Controlled Trials Database
(ISRCTN95100877).
Study flow
A resident of the Emergency Department (ED) super-
vised by a board-certified specialist in internal medicine
examined patients on admission and randomized
patients to receive antibiotics based on a procalcitonin
algorithm or based on guideline recommendations using
a centralized password-secured website. This website
provided all study-related information including patient
flow, study algorithms and guidelines for antibiotic ther-
apy based on the latest recommendations [9-11,19,20].
In patients with CAP, a prognostic assessment was con-
ducted on admission and the PSI score was calculated
on the basis of the patients’ unique set of prognostic
indicators as described elsewhere[12]. In both groups,
hospitalized patients were clinically reassessed on days
3, 5, 7 and on the day of discharge to evaluate the
course of disease. Based on guideline recommendations,
discharge was considered if oral intake was feasible, vital
signs were stable >24 h, no evidence of acute serious
co-morbidity necessitated hospitalization, and the
patient achieved pre-admission mobility state
[9-11,19,20].
Measures: Perceptions towards Outpatient Management
To study perceptions towards outpatient management, a
standardized questionnaire regarding factors necessitat-
ing inhospital treatment based on known factors from
the literature [14-16] and personal experience of the
nursing and the medical staff was developed through
rounds of consensus conferences within the research
team. To assure appropriateness of the questions, exten-
sive interviews were performed in a small subset of
patients and answers were compared to the survey
results. To assess content validity and clarity of the
items, the survey was reviewed by independent physi-
cians, nurses, patients and relatives. The feedback was
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reworded until ambiguous phrasing was sorted out.
In order to obtain estimations about necessity of hos-
pitalization at the time point of patients’ admission, and
estimations about needed length of stay at the time
point of discharge, we performed two interviews: first, a
forward-looking questionnaire was completed upon
admission focusing on the necessity of hospitalization;
second, a similar but backward-looking questionnaire
was completed before hospital discharge. The question-
naires were used to collect information from patients,
relatives, physicians and the nursing staff. It was
designed to document perceptions towards the feasibility
of outpatient management over 5 predefined dimensions
(medical, nursing, organizational factors, and patients’
and relatives’ preferences). Thereby, patients’ and rela-
tives’ preference was defined as the request of patients
or relatives with or without specified reasons. The
importance of each of these factors had to be quantified
on a continuous scale ranging from 0-100% (not impor-
tant - very important). In addition, these 5 factors were
further subdivided into: (a) medical factors (severe infec-
tion, expected adverse outcome, relevant comorbidities,
need for diagnostic workup, need for intravenous ther-
apy, others); (b) nursing factors (need for support in
activities of daily living, with oral drug intake, with per-
sonal hygiene, mobility, others); (c) patient specific fac-
tors (patients preference); (d) relatives specific factors
(no capacity to take care of the patient, relatives prefer-
ence); and (e) organizational factors (waiting for
approval of health insurance coverage, waiting for place-
ment in nursing home, organization of outpatient nur-
sing care ("Spitex”), inhospital organizational reason,
preparation of discharge and others). The specific ques-
tionnaire items are displayed in Additional file 1.
Data for the current study were collected by trained
study nurses, research fellows and medical students.
Within 3 days of admission to hospital they interviewed
patients, one of their relatives in case they played an
active role in the decision making about hospitalization
and if it was possible to contact them, the treating phy-
sician and the nurse in charge. Within 3 days before
hospital discharge the same 4 parties were re-inter-
viewed using the same questionnaire, but from a back-
ward-looking perspective. At that time-point, it was
requested to estimate how many days the hospital stay
could have been shortened.
Other Variables
The PSI score categorizes patients into 5 classes: those
in class I-III (PSI = 90) designate lower risk patients
with an estimated mortality of <1-3% and those in class
IV-V (PSI > 90) represent high risk individuals with an
estimated mortality of around 10% and 30%, respectively
[12]. As outlined by guidelines, the PSI is an effective
tool to support physicians in taking decisions regarding
patient management [9-11].
Statistical Analysis
In a first step, we calculated descriptive statistics of base-
line characteristics within 4 patients’ groups according to
their underlying diagnoses (low risk CAP (PSI I-III), high
risk CAP (PSI IV-V), ECOPD and acute bronchitis);
thereby, results are presented as frequencies (%) or med-
ians (interquartile range, IQR) and multigroup compari-
sons were done with Kruskal-Wallis or Chi-Square tests
as appropriate. In a second step, we analyzed the results
of the questionnaire within the 4 diagnoses groups and
present data as frequencies (%) and graphically display
them. Multigroup comparison of binary data was done
with Chi-Square tests.
All testing was two-tailed and p values less than
0.05 were considered to indicate statistical significance.
All statistical analyses were performed using STATA 9.2
(Stata Corp, College Station, Tex).
Results
Baseline characteristics
This study includes 566 inpatients with LRTIs out of a
total of 729 patients enrolled in the first winter season
of the ProHOSP study [17,18]. The remaining 163
(22.4%) patients were not included because of outpatient
therapy (n = 84), immediate adverse outcome (n = 25)
or because they were not able or willing to participate
(n = 54). In the participating 566 patients, CAP was
diagnosed in 396 (70%), ECOPD in 103 (18%) and acute
bronchitis in 45 (8%). In patients with CAP, severity
assessment according to the PSI classified 181 as low
risk CAP patients (PSI I-III) and 215 as high risk CAP
patients (PSI IV-V). The 22 (4%) patients with other
final diagnoses than LRTI were not further considered
for this analysis, thus the total number of patients ana-
lyzed is 544.
The median age of the overall study population was
74 years (IQR 61-82) and 43.9% were females. For the
purpose of this study, patients were divided into 4 sub-
group categories according to their underlying diagnosis:
low risk CAP (PSI I-III), high risk CAP (PSI IV-V),
ECOPD and acute bronchitis. Detailed baseline charac-
teristics of the study population including demographic
and clinical data, co-existing illnesses and 30-day-out-
comes are summarized in Table 1. As expected, high
risk CAP patients were older, more often nursing home
residents and had higher rates of comorbidities and
adverse outcome. The overall 30-day mortality rate was
3.3% (18 out of 544). Mortality was highest for patients
with high risk CAP (5.6%), lower for patients with acute
bronchitis (2.2%) or ECOPD (3.3%) and lowest for low
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stay was 9 (IQR 5-13) days; it was highest in high risk
CAP (10 (IQR 7-15) days) and ECOPD patients (8 (IQR
5-12) days) and lowest in low risk CAP (7 (IQR 5-11)
days) and acute bronchitis patients (6 (IQR 4-10) days)
(Kruskal-Wallis P < 0.001). In some patients with
immediate adverse outcomes and severest medical con-
dition the completion of the questionnaire was not pos-
sible, thus the rate of adverse outcomes is lower as
compared to original study population [17]. Randomiza-
tion of patients had no influence on the length of hospi-
t a ls t a ya n do nt h et i m et oa d v e r s eo u t c o m e si n c l u d i n g
mortality and was thus not further considered (hazard
ratio 0.99 (95%CI 0.84-1.18) and 1.20 (95%CI 0.46-3.11),
respectively).
Results of the questionnaire
A total of 180 residents and 62 senior residents cared
for the patients at the 6 sites participating. The return
rate of the questionnaires on admission and before dis-
charge was 92.1% (n = 501) and 84.5% (n = 460) for
physicians, 84.0% (n = 457) and 76.5% (n = 416) for
nurses, 84.7% (n = 461) and 77.4% (n = 421) for patients
and 27.8% (n = 151) and 26.8% (n = 146) for relatives.
Questionnaires were only distributed to relatives if
patients agreed, if relatives played an active role in the
decision making about hospitalization and if it was pos-
sible to contact them.
Overall on admission, 12.6% (n = 63) of the physi-
cians, 15.1% (n = 69) of the nurses, 18.0% (n = 83) of
patients and 5.2% (n = 8) of the relatives stated, that
outpatient treatment would be possible. At hospital dis-
charge, 31.1% (n = 144) and 32.2% (n = 134) of the phy-
sicians and nurses declared that earlier discharge would
have been possible with a median of 2 (IQR 1-3) and 2
(IQR 2-3) days. In comparison, only 11.6% (n = 49) and
4.1% (n = 6) of patients and relatives declared at hospi-
tal discharge that earlier discharge would have been pos-
s i b l ew i t ham e d i a no f2( I Q R1 - 3 )a n d2( I Q R1 - 2 )
(Kruskal-Wallis, p < 0.001). Figure 1 shows detailed esti-
mations of physicians’,n u r s e s ’,p a t i e n t s ’ and relatives’
perceptions about possible outpatient treatment on
admission and at discharge in subgroups of low and
high risk CAP, acute bronchitis and ECOPD patients. In
all LRTI subgroups, physicians, nurses, patients and
relatives had similar perceptions and stated on admis-
sion that in about 10-20% and at discharge in about
20- 40% outpatient management would have been
Table 1 Baseline data for all patients (n = 544) with respect to the underlying diagnosis
P value**
CAP
Low Risk
(n = 181)
CAP
high Risk
(n = 215)
Acute bronchitis
(n = 45)
Exacerbation of COPD
(n = 103)
Demographics
- Age (years, ǂ)* 61 (47-74) 80 (73-85) 73 (60-82) 76 (65-82) <0.001
- Gender (%, male)* 87 (48.1) 138 (64.2) 20 (44.4) 60 (58.3) 0.004
- Nursing home resident (%)* 5 (2.8) 16 (7.4) 2 (4.4) 7 (6.8) 0.14
Clinical signs
- Systolic Blood pressure (mmHg)* 130 (118-150) 130 (117-146) 136 (120-150) 139 (120-150) 0.34
- Pulse rate (bpm)* 98 (80-108) 95 (80-110) 84 (71-100) 91 (82-105) 0.034
- Respiratory rate (bpm)* 20 (16-24) 20 (16-30) 20 (16-24) 24 (18-28) <0.001
- Temperature (°C)* 38.2 (37.4-38.8) 38.1 (37.4-38.9) 37.1 (36.7-38.2) 37.2 (36.5-38.0) <0.001
Comorbidity
- Chronic heart failure* 6 (3.3) 64 (29.8) 7 (15.6) 16 (15.5) <0.001
- Cerebrovascular disease* 6 (3.3) 27 (12.6) 4 (8.9) 8 (7.8) 0.01
- Renal dysfunction* 15 (8.3) 70 (32.6) 16 (35.6) 19 (18.4) <0.001
- Neoplastic disease* 4 (2.2) 53 (24.7) 6 (13.3) 9 (8.7) <0.001
- Pneumopathy 47 (26.0) 81 (37.7) 0 (0) 103 (100) <0.001
- Diabetes mellitus 22 (12.2) 46 (21.4) 8 (17.8) 21 (20.4) 0.092
30 days outcome
- Length of hospital stay (ǂ) 7 (5-11) 10 (7-15) 6 (4-10) 8 (5-12) <0.001
- Mortality (%) 1 (0.6) 12 (5.6) 1 (2.2) 4 (3.9) 0.051
- ICU admission (%) 10 (5.5) 25 (11.6) 2 (4.4) 6 (5.8) 0.063
*criteria included in the PSI, ǂ median (Interquartile range IQR)
CAP denotes community acquired pneumonia, low risk PSI includes PSI classes I-III, high risk PSI includes PSI classes IV-V, COPD chronic obstructive pulmonary
disease, ICU Intensive Care Unit
**P values are calculated from Kruskal-Wallis or Chi-Square tests
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results of the survey in all LRTI subgroups.
The principle factors, which made inpatient treatment
necessary, had to be quantified on a scale from 0-100%
(Figure 2 and 3). Overall on admission and at discharge,
and in all LRTI subgroups, medical reasons were per-
ceived to be most important, respectively, by all parties
to a similar extent (Kruskal-Wallis on admission p =
0.24; at discharge: 0.32): physicians (86.8% and 81.7%),
nurses (87.4% and 83.1%), patients (85.7% and 87.2%)
and relatives (80.9% and 85.3%). Following medical rea-
sons, the predominant factors necessitating inpatient
management overall and in all LRTI subgroups were
patients’ preferences, nursing factors, relatives’ prefer-
ences and organizational factors.
We further asked to specify the main medical factors
subdivided into the following categories: fear of severe
infection, fear of adverse outcome, severe comorbidities,
requiring further diagnostic work up, need for intrave-
nous therapy, other reasons. Overall, fear of severe
infection was the most important factor on admission,
followed by need for intravenous therapy and comorbid-
ities. Table 2 shows details on medical reasons in all
subgroups of patients.
Similarly, we asked to further specify nursing reasons
into the following categories: support in activities of
daily living, oral drug intake, personal hygiene, mobility,
others. Overall in all subgroups, support in activities of
daily living was the most important nursing reason on
admission and at discharge necessitating inpatient treat-
ment. Table 3 shows details of nursing factors for all
subgroups.
Discussion
Site-of-care decisions in LRTIs are pivotal, yet admission
rates and duration of hospital stays vary considerably
and appear non-standardized in real-life clinical practice
[25,26]. This survey provides new insights into percep-
tions of physicians, nurses, patients and relatives about
possible outpatient management, the perceived neces-
sary length of hospital stay and reasons necessitating
inpatient management in patients with different severi-
ties of LRTIs. This survey revealed that independently of
type of LRTI and expected mortality, most patients with
LRTIs are hospitalized because physicians, nurses,
patients and relatives all believe that inpatient manage-
ment is indicated due to medical reasons, particularly
fear of severe infection. To a lesser extend nursing rea-
sons and patients’ and relatives’ personal preferences
were mentioned.
It is known that outpatient management has advan-
tages over inpatient management. Patients treated in
their home are able to resume normal activities sooner
and are less likely to experience complications such as
thrombo-embolic events, secondary infections with
more virulent and resistant pathogens found in the hos-
pital (nosocomial infections) and intravascular catheter-
related infections since antibiotic treatment is usually
practiced with an oral antimicrobial agent [27]. In addi-
tion, treatment at home is less expensive and studies
have demonstrated that low risk CAP patients prefer
outpatient to inpatient treatment [8]. Still, as demon-
strated in previous studies [4,28,29] as well as in the
presented study, many patients with LRTIs are treated
as inpatients even if being at a low risk for medical
complications. As inpatient management should be con-
sidered especially for patients at higher risk for compli-
cations and mortality, guidelines recommend that the
decision to hospitalize an individual patient with a LRTI
should be validated against at least one objective tool of
risk assessment[10]. In this regard, the PSI is a valid
tool. Patients with a PSI of IV or V are at increased risk
for short term mortality, and thus in these patients hos-
pitalization should be strongly considered [10,12,13].
Figure 1 Estimation if outpatient treatment would be possible on admission (dark grey) and at discharge (light grey).
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Page 5 of 10Figure 2 Reasons for inpatient treatment on admission on a scale from 0-100% in all subgroups of patients. First column (dark grey)
representing physicians, second column (very-light grey) representing nurses, third column (light grey) representing patients, fourth column
(black) representing patients’ relatives. Of note, the number of patients (n) corresponds to the total number of included patients.
Figure 3 Reasons for inpatient treatment at discharge on a scale from 0-100% in all subgroups of patients. First column (dark grey)
representing physicians, second column (very-light grey) representing nurses, third column (light grey) representing patients, fourth column
(black) representing patients’ relatives. Of note, the number of patients (n) corresponds to the total number of included patients.
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Low Risk CAP patients (PSI class I-III) High risk CAP patients (PSI class IV-V)
(n = 181) (n = 215)
Physicians Nurses Patients Relatives P
values
Physicians Nurses Patients Relatives P
values
(n = 167) (n = 154) (n = 158) (n = 45) (n = 200) (n = 182) (n = 178) (n = 67)
Fear of severe infection 40.1 40.2 53.9 46.7 <0.001 35.9 36.3 54.1 50.5 <0.001
Fear of adverse outcome 5.5 4.6 7.5 8.3 0.02 4.7 5.3 4.5 8.4 0.002
Severe comorbidities 11.3 8.9 11 15 <0.001 20.4 14.3 15.7 21.1 <0.001
Requires further diagnostic
work up
8.9 10.8 5.3 1.7 <0.001 8.6 9.4 5.4 3.2 0.03
Requires intravenous therapy 28.8 31.7 15.8 16.7 0.002 26.8 29.2 12.4 6.3 <0.001
Other reason 5.5 3.9 6.6 11.7 0.24 3.7 5.6 7.9 10.5 0.03
Patients with acute bronchitis Patients with ECOPD
(n = 45) (n = 103)
Physicians Nurses Patients Relatives P
values
Physicians Nurses Patients Relatives P
values
(n = 40) (n = 35) (n = 39) (n = 10) (n = 94) (n = 86) (n = 86) (n = 29)
Fear of severe infection 20 33.3 42.3 38.9 0.008 29.7 41.9 51.7 60 <0.001
Fear of adverse outcome 12.3 13.7 9.6 11.1 <0.001 12.7 8.9 9.5 13.3 0.007
Severe comorbidities 32.3 21.6 25 22.2 <0.001 27.2 13.7 20.7 16.7 <0.001
Requires further diagnostic
work up
18.5 7.8 5.8 0 <0.002 8.9 8.1 5.2 3.3 <0.002
Requires intravenous therapy 9.2 15.7 3.8 11.1 <0.003 14.6 21.8 6 3.3 <0.003
Other reason 7.7 7.8 13.5 16.7 0.001 7 5.6 6.9 3.3 0.092
Table 3 Main nursing factors leading to hospitalization of patients with LRTIs
Low Risk CAP patients (PSI class I-III) High risk CAP patients (PSI class IV-V)
(n = 181) (n = 215)
Physicians Nurses Patients Relatives P
values
Physicians Nurses Patients Relatives P
values
(n = 167) (n = 154) (n = 158) (n = 45) (n = 200) (n = 182) (n = 178) (n = 67)
Support in activities of daily
living
54.2 36.8 50.9 36.8 0.01 46.9 40.1 43.4 34.2 <0.001
Oral drug intake 3.4 16.7 12.3 10.5 0.75 3.4 9.7 8.5 12.3 <0.001
Personal hygiene 11.9 18.4 24.6 26.3 0.7 18.3 22.8 20.2 21.9 0.02
Mobility 18.6 13.2 10.5 15.8 0.08 22.3 18 20.2 17.8 0.034
Others 8.5 14 1.8 5.3 0.16 2.3 5.6 5.4 8.2 0.04
Patients with acute bronchitis Patients with ECOPD
(n = 45) (n = 103)
Physicians Nurses Patients Relatives P
values
Physicians Nurses Patients Relatives P
values
(n = 40) (n = 35) (n = 39) (n = 10) (n = 94) (n = 86) (n = 86) (n = 29)
Support in activities of daily
living
45.5 54.2 52.4 33.3 <0.001 52.5 34.5 46.7 60 <0.001
Dementia 300 0 0.57 3.3 1.8 0 6.7 0.23
Oral drug intake 12.1 12.5 9.5 16.7 0.01 4.9 15.9 13.3 13.3 0.003
Personal hygiene 21.2 12.5 23.8 33.3 0.03 14.8 20.4 13.3 6.7 0.02
Mobility 15.2 8.3 14.3 16.7 0.03 19.7 16.8 17.8 13.3 0.02
Others 3 12.5 0 0 0.004 4.9 10.6 8.9 0 0.23
Baehni et al. BMC Pulmonary Medicine 2010, 10:12
http://www.biomedcentral.com/1471-2466/10/12
Page 7 of 10Yet, as demonstrated by others [4,28,29] and confirmed
in the present study, a high percentage of low risk
patients with PSI I-III are still being hospitalized despite
enforced implementation to calculate the PSI and follow
its recommendation on admission in our study. Once a
patient is hospitalized, guidelines recommend that dis-
charge should be considered if oral intake is feasible,
vital signs are stable, if there is no evidence of acute ser-
ious co-morbidity requiring hospitalization and if the
patient achieves pre-admission mobility[10,11]. Still,
substantial regional and national variations of length of
stay have to be taken into account, furthermore pro-
longed hospitalization times depend on disease-related
factors, medical complications and non-clinical factors
[7]. These observations highlight the importance of phy-
sician judgment for the site-of-care decision in patients
with LRTIs. In addition, it raises the questions if physi-
cian judgment is influenced by strictly medical or, possi-
bly more important other factors such as nursing and
organizational factors, preferences and believes of
patients and their relatives, and how these factors may
interact, respectively.
Interestingly, despite enforced assessment of the PSI
during this study, physicians, nurses, patients, and rela-
tives most often justified inpatient management with
medical factors, namely fear of severe infection and fear
of complications not directly included in the PSI. To a
lesser extent nursing factors were also mentioned to be
important, mainly support in activities of daily living.
Thus, all involved parties intuitively overestimated the
disease specific risks. As the PSI is a medical risk assess-
ment tool to be used by physicians, timely information
of the nursing staff, patients and relatives about usually
lower-than-expected complications would be desirable.
In addition, similar tools should be designed for other
LRTIs than CAP, namely ECOPD and acute bronchitis.
We found a considerable length of hospital stay for all
patients and particularly in low risk CAP and acute
bronchitis patients. Many of these patients fulfilled
discharge criteria from the beginning, but still only 20-
40% of physicians and nurses and 10% of patients and
relatives believed that earlier discharge would be feasible,
mainly because of ongoing fear of severe infection and
associated complications. Interestingly, this perception
was similar prospectively on admission and retrospec-
tively at discharge. Continuous information about the
course of disease, expected risks and the possibility of
early discharge may encourage not only physicians, but
also nurses, patients and relatives to envisage discharge.
An important finding of this study is that beyond the
severity of the infection and expected risks, the need for
intravenous antibiotic treatment was often mentioned as
a medical reason necessitating inpatient management
and justifying a longer length of stay, mainly by physi-
cians and nurses. The regular evaluation of its need and
change to oral treatment as soon as possible is thus of
outmost importance and could reduce the duration of
hospitalization as well.
Interestingly, in this study physicians and nurses were
much more confident that earlier discharge would be
feasible in about one forth of patients, while patients
and relatives were much more reluctant to earlier dis-
charge. In daily practice, patients often don’th a v e
enough self-confidence and fear complications of dis-
ease. Early information of patients and relatives about
convalescence and the diverse possibilities of home nur-
sing and home caring might be an effective strategy to
empower patients for a shared decision-making about
earlier discharge.
Consistent with theoretical concepts from Glouber-
man[14,15], this study shows that not only medical but
also non-medical factors influence the site-of-care and
discharge decision in patients with LRTIs. Although the
initial site-of-care and discharge decision is primarily
made by physicians and based on medical reasons, pre-
ferences of patients and their relatives, nursing and
organizational factors are also considered (Figure 4).
Thus, specifically addressing and communicating these
Figure 4 Different factors which potentially influence the site-of-care decision.
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management might help to optimize caring and curing
procedures and to avoid unnecessary hospitalization.
Prior studies have demonstrated that outpatient man-
agement is often preferred by low risk CAP patients and
that most physicians appear not to involve patients in
the site-of-care decision [8]. However, in this study,
many patients preferred inpatient management due to
concerns regarding their medical situation and possible
complications. Patients’ concerns may be the result of
missing information on their low medical risk or mis-
communication and do not correspond with findings
from large studies[12]. A more explicit education of
patients would likely change patients’ perspectives and
thus indirectly influences the site-of-care decision.
A very recent US study found that low-risk patients
with CAP are frequently hospitalized because of comor-
bid illness, because of requests for hospitalization made
by other treating physician, the patient, or the patient’s
family or the provider’s perception that the case of
pneumonia was more severe than indicated by the PSI
[28]. In our study, comorbid disease was only mentioned
in 11% of low risk patients thus not a major driving fac-
tor. However, fear of complications and higher perceived
risk may prompt patients and relatives to request
hospitalization.
To the best of our knowledge, this is the first study to
systematically investigate perceptions of physicians,
nurses, patients and relatives about possible outpatient
management and about medical and non-medical fac-
tors that influence this decision. The strengths of this
study are the prospective conduct of this survey in a
large number of LRTI patients from 6 Swiss Hospitals
differing in size and type, including one University hos-
pital and the standardized and enforced risk assessment
of patients on admission using a centralized website.
Still, some limitations of this study need consideration.
Firstly, the survey was not numerically equally con-
ducted in each interviewed group. Questionnaires were
only distributed to relatives if they took part in the deci-
sion making about hospitalization and therefore relatives
are underrepresented. Secondly, older and severely ill
patients, as well as some of the relatives may have been
overstrained by this survey asking for personal estima-
tions. Similarly, physicians and nurses may not have
answered all questions independently and adequately
because of time constraints and mutual interaction.
Finally, the results of this study may not unconditionally
apply to other settings or geographic regions.
Conclusion
In conclusion, we found that the complication and mor-
tality risks in LRTIs are in general overestimated by
physicians, nurses, patients and relatives possibly leading
to higher rates of inpatient management and longer hos-
pital stays. We hypothesize that more objective and
easy-to-use assessment and information of the medical
staff, but especially patients, their relatives and the nur-
sing staff with simpler, more convenient, appropriate
and persuasive risk assessment tools and information
would be useful. Furthermore, a more explicit discussion
between physicians, nursing staff, patients and their rela-
tives about expected risks and existing fears, and the
consideration of medical as well as non-medical factors
would help to avoid unnecessary admissions, to shorten
necessary hospitalizations and to optimize caring and
curing procedures, and therefore improve the cost-effi-
ciency of the treatment and optimize the allocation of
our limited health-care resources.
Additional file 1: Questionnaire items. The specific questionnaire items
was used within this study to assess perception of physician, nurses,
patients and relatives are presented
Additional file 2: Survey results for patients with low and high risk
CAP on admission and at discharge. Detailed results for patients with
community-acquired pneumonia (CAP) with low risk PSI classes (I-III) and
high risk classes (IV-V); Initial survey (1-3 days after hospitalization) in the
upper part, follow up survey (1-3 days before discharge) in the lower
part
Additional file 3: Survey results for patients with ECOPD and acute
bronchitis on admission and at discharge. Detailed results for patients
with exacerbation of COPD (ECOPD) and acute bronchitis classes (IV-V);
Initial survey (1-3 days after hospitalization) in the upper part, follow up
survey (1-3 days before discharge) in the lower par
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